Literature DB >> 62790

Relationship between the C5 peptides chemotactic for leukocytes and tumor cells.

A G Romualdez, P A Ward, T Torikata.   

Abstract

A reciprocal relationship has been demonstrated between the generation of the leukotactic and the tumor cell chemotactic peptides from C5. Trypsin-produced C5 leukotactic peptides can be converted into tumor cell chemotactic factors by treatment with tumor cell extracts or by incubation with the alpha-globulin chemotactic factor inactivator (CFI) isolated from human serum. A similar CFI isolated from rat serum can, like the alpha-globulin CFI from human serum, generate the tumor cell chemotactic factor from the whole human serum. These results suggest that the tumor cell chemotactic factor derives from the same portion of the C5 molecule as the leukotactic peptide. Furthermore, it appears that the critical change may be cleavage of the amino-terminal portion of the leukotactic peptide. In addition, it has been shown that most normal tissues contain an enzyme-like material that is able to generate in normal human serum a factor chemotactic for tumor cells. The implications of these findings are discussed.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 62790

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  SV40 transformed fibroblasts recognize the same 140 kD fibronectin chemotactic fragment as non-transformed cells.

Authors:  A Albini; G Allavena; H Richter; B F Pontz; S Parodi; L Santi
Journal:  Experientia       Date:  1985-12-15

2.  Digestion of the fifth component of complement by leukocyte enzymes. Sequential generation of chemotactic activities for leukocytes and for tumor cells.

Authors:  F W Orr; J Varani; D L Kreutzer; R M Senior; P A Ward
Journal:  Am J Pathol       Date:  1979-01       Impact factor: 4.307

3.  Chemotactic factor for tumor cells derived from the C5a fragment of complement component C5.

Authors:  W Orr; S H Phan; J Varani; P A Ward; D L Kreutzer; R O Webster; P M Henson
Journal:  Proc Natl Acad Sci U S A       Date:  1979-04       Impact factor: 11.205

4.  Partial characterization of a bone-derived chemotactic factor for tumor cells.

Authors:  F W Orr; J Varani; M D Gondek; P A Ward; G R Mundy
Journal:  Am J Pathol       Date:  1980-04       Impact factor: 4.307

5.  Collagen and collagen-derived fragments are chemotactic for tumor cells.

Authors:  G R Mundy; S DeMartino; D W Rowe
Journal:  J Clin Invest       Date:  1981-10       Impact factor: 14.808

6.  A comparison of the migration patterns of normal and malignant cells in two assay systems.

Authors:  J Varani; W Orr; P A Ward
Journal:  Am J Pathol       Date:  1978-01       Impact factor: 4.307

7.  The chemotactic response of tumor cells. A model for cancer metastasis.

Authors:  W C Lam; E J Delikatny; F W Orr; J Wass; J Varani; P A Ward
Journal:  Am J Pathol       Date:  1981-07       Impact factor: 4.307

8.  Chemotaxis of metastatic tumor cells.

Authors:  J Varani
Journal:  Cancer Metastasis Rev       Date:  1982       Impact factor: 9.264

9.  Cell behavior in Dictyostelium discoideum: preaggregation response to localized cyclic AMP pulses.

Authors:  R P Futrelle; J Traut; W G McKee
Journal:  J Cell Biol       Date:  1982-03       Impact factor: 10.539

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.